Methods of administering elagolix | Patent Application Number 16722741

16722741
Not Appealed
Patent NumberUS 10682351 B2
Publication NumberUS 20200121680 A1
Filled DateDec 20, 2019
Priority DateSep 1, 2015
Inventor/ApplicantsCheri E. Klein
Ahmed Salem
Sandra L. Goss
Juki Wing-Keung Ng
ExaminesREESE, HEIDI L
Art Unit1657
Technology Center1600
Assignments
Abbvie Inc.
Current
Abbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.